Product NDC: | 53157-123 |
Proprietary Name: | Leukotrap - CP2D Solution |
Non Proprietary Name: | Anticoagulant Citrate Phosphate Double Dextrose |
Active Ingredient(s): | 3.57 g/70mL & nbsp; Anticoagulant Citrate Phosphate Double Dextrose |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53157-123 |
Labeler Name: | Haemonetics Manufacturing Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA820915 |
Marketing Category: | NDA |
Start Marketing Date: | 19831109 |
Package NDC: | 53157-123-01 |
Package Description: | 6 BAG in 1 POUCH (53157-123-01) > 70 mL in 1 BAG (53157-123-00) |
NDC Code | 53157-123-01 |
Proprietary Name | Leukotrap - CP2D Solution |
Package Description | 6 BAG in 1 POUCH (53157-123-01) > 70 mL in 1 BAG (53157-123-00) |
Product NDC | 53157-123 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Anticoagulant Citrate Phosphate Double Dextrose |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19831109 |
Marketing Category Name | NDA |
Labeler Name | Haemonetics Manufacturing Inc |
Substance Name | DEXTROSE |
Strength Number | 3.57 |
Strength Unit | g/70mL |
Pharmaceutical Classes |